Acute myocardial infarction associated with Captagon use

References (1)

1. Kraemer T, Maurer HH. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. Ther Drug Monit 2002; 24: 277-89. [CrossRef] 2. Nickel B, Niebch G, Peter G, von Schlichtegroll A, Tibes U. Fenetylline: new results on pharmacology, metabolism and kinetics. Drug Alcohol Depend 1986; 17: 235-57. [CrossRef] 3. Cockings JG, Brown M. Ephedrine abuse causing acute myocardial infarc- tion. Med J Aust 1997; 167: 199-200. 4. Packe GE, Garton MJ, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J 1990; 64: 23-4. [CrossRef] 5. Westover AN, Nakonezny PA, Haley RW. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend 2008; 96: 49-56. [CrossRef] 6. Mendelson J, Uemura N, Harris D, Nath RP Fernandez E, Jacob P 3rd, et al. Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther 2006; 80: 403-20. [CrossRef] 7. Kolodgie FD, Wilson PS, Mergner WJ, Virmani R. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol 1999; 66: 109-22. [CrossRef] 8. McCord J, Jneid H, Hollander JE, de Lemos JA, Cercek B, Hsue P et al. Management of cocaine-associated chest pain and myocardial infarction: a scien- tific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008; 117: 1897-907. [CrossRef]